252 related articles for article (PubMed ID: 24934303)
1. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.
Mani J; Jin N; Schmitt M
Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of BK and JC polyomavirus reactivation following renal transplantation.
Saundh BK; Tibble S; Baker R; Sasnauskas K; Harris M; Hale A
J Clin Pathol; 2010 Aug; 63(8):714-8. PubMed ID: 20702473
[TBL] [Abstract][Full Text] [Related]
3. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
4. [BK and JC viruses--2 polyomaviruses causing disease in immunosuppressed patients].
Bogdanovic G; Grandien M; Brytting M; Fridell E
Lakartidningen; 1992 Nov; 89(46):3925-6. PubMed ID: 1334184
[TBL] [Abstract][Full Text] [Related]
5. Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
Schneidewind L; Neumann T; Knoll F; Zimmermann K; Smola S; Schmidt CA; Krüger W
Acta Haematol; 2017; 138(1):3-9. PubMed ID: 28591758
[TBL] [Abstract][Full Text] [Related]
6. A review on JC virus infection in kidney transplant recipients.
Delbue S; Ferraresso M; Ghio L; Carloni C; Carluccio S; Belingheri M; Edefonti A; Ferrante P
Clin Dev Immunol; 2013; 2013():926391. PubMed ID: 23424601
[TBL] [Abstract][Full Text] [Related]
7. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy.
Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS
Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645
[TBL] [Abstract][Full Text] [Related]
8. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.
Ambalathingal GR; Francis RS; Smyth MJ; Smith C; Khanna R
Clin Microbiol Rev; 2017 Apr; 30(2):503-528. PubMed ID: 28298471
[TBL] [Abstract][Full Text] [Related]
9. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
10. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.
Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M
Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933
[TBL] [Abstract][Full Text] [Related]
11. Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.
Nelson AS; Yalamarthi N; Yong MK; Blyth E
Curr Opin Infect Dis; 2021 Dec; 34(6):627-634. PubMed ID: 34751182
[TBL] [Abstract][Full Text] [Related]
12. BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation.
Pello OM; Innes AJ; Bradshaw A; Finn SA; Uddin S; Bray E; Olavarria E; Apperley JF; Pavlů J
Eur J Haematol; 2017 Jun; 98(6):632-634. PubMed ID: 28083990
[TBL] [Abstract][Full Text] [Related]
13. T cell therapies for human polyomavirus diseases.
Davies SI; Muranski P
Cytotherapy; 2017 Nov; 19(11):1302-1316. PubMed ID: 28927823
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of BK and JC virus DNA positivities by real-time polymerase chain reaction in the clinical samples of patients with high risk].
Rota S; Fidan K; Bozdayı G; Dalgıç A; Fidan I; Sucak G; Müderris T
Mikrobiyol Bul; 2011 Apr; 45(2):280-7. PubMed ID: 21644071
[TBL] [Abstract][Full Text] [Related]
15. A serological investigation of BK virus and JC virus infections in recipients of renal allografts.
Andrews CA; Shah KV; Daniel RW; Hirsch MS; Rubin RH
J Infect Dis; 1988 Jul; 158(1):176-81. PubMed ID: 2839580
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells.
Holland EM; Gonzalez C; Levy E; Valera VA; Chalfin H; Klicka-Skeels J; Yates B; Kleiner DE; Hadigan C; Dave H; Shalabi H; Hickstein DD; Su HC; Grimley M; Freeman AF; Shah NN
Front Immunol; 2021; 12():801281. PubMed ID: 34975916
[TBL] [Abstract][Full Text] [Related]
17. Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait.
Chehadeh W; Nampoory MR
J Med Virol; 2013 Sep; 85(9):1624-31. PubMed ID: 23775307
[TBL] [Abstract][Full Text] [Related]
18. The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?
Satyanarayana G; Marty FM; Tan CS
Transpl Infect Dis; 2014 Aug; 16(4):521-31. PubMed ID: 24834968
[TBL] [Abstract][Full Text] [Related]
19. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer.
Imperiale MJ
Virology; 2000 Feb; 267(1):1-7. PubMed ID: 10648177
[No Abstract] [Full Text] [Related]
20. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
Drachenberg CB; Hirsch HH; Papadimitriou JC; Gosert R; Wali RK; Munivenkatappa R; Nogueira J; Cangro CB; Haririan A; Mendley S; Ramos E
Transplantation; 2007 Aug; 84(3):323-30. PubMed ID: 17700156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
